GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$157.88
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -95.07x
- Price / sales
- 17.91x
- Price / cash flow
- -114.41x
Enterprise value
- Enterprise value
- $21.8B
- EV / sales
- 18.45x
- EV / EBITDA
- -53.09x
- EV / EBIT
- -46.42x
- Market cap
- $21.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026